Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Innovent and Lilly Form Major Cancer Biologics Collaboration

publication date: Mar 20, 2015
Innovent Biologics, a four-year-old Suzhou biopharma, announced a very broad ten-year cross-border collaboration with Eli Lilly that includes as many as six potential biologic cancer treatments. Lilly will make a $56 million upfront payment, with milestones for a single immuno-oncology drug candidate totaling $400 million. Further financial details were not disclosed. For Lilly, Innovent is a prize China collaboration. In its short four-year history, Innovent has built a $140 million facility (underwritten by Suzhou's BioBay Park) that is compliant with US/EU/China standards and raised $100 million in venture capital earlier this year. The company has developed a portfolio of ten biologic drug candidates, a combination of novel molecules and biosimilars. More details....

Stock Symbol: (NYSE: LLY)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here